Iridex (IRIX) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2026)
Iridex (IRIX) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 8.20% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 88.89% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -30.89% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 47.37% |
| 10 | Iridex | 19.30 Mn | 14.71 Mn | 4.74 Mn | 70.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 70.00% |
| Jan 3, 2026 | 80.00% |
| Sep 27, 2025 | 25.00% |
| Jun 28, 2025 | 62.50% |
| Mar 29, 2025 | 52.38% |
| Dec 28, 2024 | 72.22% |
| Sep 28, 2024 | -9.09% |
| Jun 29, 2024 | 5.88% |
| Mar 30, 2024 | -61.54% |
| Dec 30, 2023 | -157.14% |
| Sep 30, 2023 | 0.00% |
| Jul 1, 2023 | -21.43% |
| Apr 1, 2023 | 13.33% |
| Dec 31, 2022 | -170.00% |
| Oct 1, 2022 | 21.43% |
| Jul 2, 2022 | -255.56% |
| Apr 2, 2022 | -7.14% |
| Oct 2, 2021 | -16.67% |
| Jul 3, 2021 | 145.00% |
| Apr 3, 2021 | -16.67% |